All Articles

3325 Articles

Litigation Insurance is Not Just for Plaintiffs Anymore

Industry norms suggest that in commercial disputes, litigation insurance for defendants is not part of the equation. Usually, it’s claimants who make use of this type of after-the-event insurance. But why does this perception persist? Legal Futures UK suggests that because litigation insurance can meet adverse costs, it makes sense for both plaintiffs and defendants. For defendants, this is particularly vital in the case of cross disputes, or instances when the defendant didn’t want to go to court in the first place. After-the-event insurance is only enforceable when a case is successful. Most insurance policies state that a successful case is one where the legal action is settled or adjudicated with terms that are favorable to the insured. Litigation insurance is a common way to manage risk, which is especially valuable to defendants who have fewer options and less control than plaintiffs. After-the-event insurance helps defendants mitigate adverse cost exposure, allowing defendants to devote more resources toward a strong legal defense team. Ultimately, underwriters should be tailoring litigation insurance to meet the unique needs of clients—be they plaintiffs or defendants. For defendants, calculating the insurance premium against the possible adverse costs is an easy choice.

Burford Capital surpasses $100 million in Equity Project commitments

Burford Capital—the leading global finance and asset management firm focused on law—today announces that it has crossed a significant milestone in its groundbreaking initiative designed to increase diversity in the business of law, with more than $100 million in cumulative Equity Project commitments made to back commercial litigation and arbitration led by female and racially diverse lawyers.

The Equity Project earmarks legal finance capital to promote diversity by giving historically underrepresented lawyers an edge as they pursue leadership positions in significant commercial litigations and arbitrations. The Equity Project also augments companies’ ESG and DEI initiatives by providing incentives for the firms that represent them to appoint historically underrepresented lawyers and to award them origination credit.

The Equity Project first launched in October 2018 with $50 million earmarked to back commercial matters led by women. After having committed more than that amount by December 2020, Burford announced an expansion of The Equity Project in October 2021, earmarking a further $100 million, broadening The Equity Project’s mission to promote both racial and gender diversity in law, and pledging to contribute a portion of its profits from successfully resolved phase two Equity Project matters to organizations that promote development for female and racially diverse lawyers on its clients’ behalf.

As of February 28, with more than half of phase two funds committed, Burford has now made more than $100 million in cumulative commitments to Equity Project matters.

Matters funded to date in this phase of The Equity Project include contract disputes, antitrust, federal statutory, IP/patent and treaty arbitration matters, with female and racially diverse litigators in leadership roles (first or second chair) as well as women-owned firms. Clients include large corporations and large litigation boutiques.

Aviva Will, Co-COO of Burford Capital and leader of The Equity Project initiative, said: “We are delighted by the overwhelming response to phase two of The Equity Project, particularly from corporate clients, and that’s reflected in the fact that we have crossed this significant milestone in a short period of time. The Equity Project is core to Burford’s culture and a part of our daily work, and we look forward to committing the remaining funding soon.”

David Perla, Co-COO of Burford Capital, said: “I’m very pleased to see the rapid commitment of our capital in phase two of The Equity Project. As the industry leader, we recognize that we may be the only commercial legal finance company with the resources to make such a significant financial commitment to increasing diversity in law. We are aware of our unique position and take seriously the significant impact Burford can have on the legal market in all the work we do.”

The Equity Project is supported by 26 Champions from leading companies, law firms and organizations. A list of Champions and more information about The Equity Project can be found on Burford’s website.

‘Secondary’ Investing in Litigation Finance: Why, why now, and how to approach investing in Lit Fin Secondaries

The following article is part of an ongoing column titled ‘Investor Insights.’  Brought to you by Ed Truant, founder and content manager of Slingshot Capital, ‘Investor Insights’ will provide thoughtful and engaging perspectives on all aspects of investing in litigation finance.  Executive Summary
  • Evolution of Litigation Finance necessitates the need for a secondary market
  • Investing in Litigation Finance secondaries is much more difficult than other forms of private equity due to the inherent difficulty in valuing the ‘tail’
  • Experts should be utilized to assess case merits and valuation
  • Life cycle of litigation finance suggests timing is right for secondaries
Slingshot Insights:
  • Investing in the ‘tail’ of a portfolio, where most secondary transactions will take place, can be more difficult than primary investing
  • Dynamics of the ‘tail’ of a portfolio are inherently riskier than a whole portfolio, which is partially offset by enhanced information related to the underlying cases
  • Secondary portfolios are best reviewed by experts in the field and each significant investment should be reviewed extensively
  • Derive little comfort from portfolios that have been marked-to-market by the underlying manager
  • Investing in secondaries requires a discount to market value to offset the implied volatility associated with the tail
In my discussions with litigation finance institutional investors, the topic of secondary investments has been raised a number of times by those who understand the economics of the asset class and are seeking to take advantage of some of the longer duration cases and portfolios in existence.  In this article, I explore why there is interest in the secondary market, why now, and how best to approach investing in secondary investments, as well as some watch-outs. The concept of secondaries has been well established in the private equity world, specifically leveraged buy-out private equity, and, having been in existence for a couple of decades now, represents a mature strategy not only within leveraged buy-out, but also infrastructure, real estate, venture capital, growth equity, etc.  So, it is not surprising to see the concept applied to litigation finance. As David Ross, Managing Director & Head of Private Credit at Northleaf Capital Partners, notes "Having been active in private equity secondaries for close to twenty years, Northleaf has extended its secondaries expertise over the past few years to include investments in litigation finance, which is an area that provides attractive and uncorrelated returns for our investors. Executing investments in litigation finance requires dedicated expertise but can provide attractive transaction dynamics for both existing investors seeking liquidity and prospective investors capable of underwriting and structuring an attractive secondary." To begin with, let’s first define what constitutes a “secondary” transaction.  Essentially, a secondary is any transaction where one party is acquiring the interests from the original investor (the ‘primary’ investor) in an investment opportunity.  In the case of litigation finance, this could take the form of a single case investment, portfolios or LP interests in funds, among other opportunities.  In this sense, they are the ‘second’ investor to own the investment, as they have acquired their interest from the first investor through the acquisition transaction. Types of Secondaries In order for a secondary market to make sense, at least for institutional investors, there needs to be a sufficient number of opportunities that are adequately aged to allow for one party to sell at typically, but not always, a discount to either their original cost or their current fair market value of the investment.  These opportunities can arise for a number of reasons, as outlined below. For fund managers, they may be looking to raise a new, larger fund, and in order to do so they will have to demonstrate that they are good stewards of capital and that they can produce attractive returns to investors relative to the risk they assume.  If these managers do not have a sufficient number of realizations in their predecessor portfolios, they will have to create a track record by selling off interests in single cases or entire portfolios.  In this way, they will receive arm’s length validation that their portfolio has intrinsic value, with the idea that other potential investors should take comfort in the fact that a third party has assessed the attractiveness of opportunities and decided to invest at a value that is, hopefully, in excess of their original cost, or matches their internal assessment of fair market value.  Of course, this assumes that the purchaser is a knowledgeable purchaser of litigation finance assets and an expert at valuing litigation finance investments, of which few exist in the world, as valuation is perhaps more art than science. A relatively recent public example of this is Burford’s multiple secondary sales of interests in their Petersen case, which was sold in several tranches at increasing valuations as Burford continued to de-risk their investment through positive case developments during its hold period.  According to the Petersen article hyperlinked above, Burford generated $236 million in cash from selling off interests in the claim, which significantly benefited its reported profitability and cashflow, and evidently, fueled its stock price at the time.  All in all, a smart move by Burford to hedge its bets and de-risk its investment by selling down to other investors.  However, it remains to be seen whether those who acquired the secondary interests in Peterson were as astute as the sellers, time will tell. For investors, they may be in a situation where they are in a liquidity squeeze, and could be frustrated with the duration of the litigation finance portfolio and therefore wish to exit the remainder of their investment to redeploy capital into a new fund or a new strategy. They could also have had a change in management which created a shift in strategy, or any number of other causes.  For investors in individual cases or funds, they currently face a difficult task in finding a secondary investor to acquire their interests, which can be made more difficult by the fact that the manager may not be motivated to find them a purchaser, as there is no economic incentive to do so. The fate of these investors remains in the hands of the manager.  However, if there are enough investors clamoring for liquidity, then the manager may be forced to hire an investment bank or another intermediary expert to solicit the markets’ appetite and obtain bids for the portfolio; but this will come at a cost which is typically assumed by the selling investor. But is a secondary a “realization”? The short answer is NO! While a secondary can be an indication of perceived value in the market, it is simply a point-in-time estimate of value by the new, prospective owner that makes a series of assumptions to underlie their valuation. As such, it has no bearing on whether the case is more or less likely to settle or win, whether the defendant has the resources to pay, and whether it could take two years or ten years to collect. Litigation is well known to have a binary outcome.  In the context of large cases where there are significant dollars at risk, it may be in the best interests of the defendant to take the trial risk and deal with the consequences by ultimately settling for a fraction of the damages after the court decision is handed down.  In the Petersen case referenced above, it has been felt by some in the market that an award could still be years away (in the absence of collection frustration tactics that the Argentinian government may pursue); and even then, there is some concern that the decision may allow for damages denominated in Argentine pesos, which have been significantly devalued since the case began.  In addition, the Argentine government has defaulted on its sovereign debt a few times over the last numbers of years and is currently in default on its International Monetary Fund loans, so it is difficult to assess the risk of collectability. Just because you win a case, doesn’t mean you get to collect the spoils. Collection is a whole other issue and perhaps a topic for another article.  Suffice it to say, that a case is not completely de-risked until the ‘cash is in the bank’ (your bank account, not the lawyer’s trust account). So, I personally would take very little comfort in the fact that another party has looked at a case and made a decision that it has value – you would have to have a deep understanding of that buyer’s motivations (are they merely incentivized to get money invested? Are they motivated by Litigation Finance FOMO?) and that buyer’s ability to value litigation, which is difficult to do with accuracy because of the number of variables & uncertainties involved. Why are litigation finance secondaries interesting? Perhaps the better question is, “Are litigation finance secondaries interesting?” And the answer is, “It depends”. When you look at a portfolio of litigation finance single cases, there are a number of individual investments that typically resolve early in the fund’s life, and this usually gives rise to attractive internal rates of return (“IRR”), but low multiples of  invested capital (“MOIC”); then, there are those that resolve in and around the 30 month mark, which is a fairly typical duration, which should result in stronger MOICs and perhaps somewhat lower IRRs; and then, there is the ‘tail’ of the portfolio (see chart below).  The ‘tail’ of a portfolio refers to those cases that are outside of the normalized expectation for case realizations in terms of duration that reside in the portfolio near the end of, or perhaps even outside of, the investment vehicle’s life.  These cases could be outside the normal time distribution because the cases are highly complex, the defendant has tried to procedurally frustrate & delay the litigation, the case is going through a long drawn out trial or arbitral process, or the nature of the case simply takes longer (intellectual property, international arbitration, etc.) among other explanations. Often, when an investor is provided with a secondary opportunity, they are quite likely looking at investing in the ‘tail’ of the portfolio because the early part of the portfolio has already been resolved, and the proceeds have either been paid out or used to fund the cases remaining in the tail.  Investing in the tail has many implications for expected outcomes. The potential tail outcomes, as depicted with red arrows in the chart below, indicate the uncertainty in both quantum and duration of the tail. In part 2 of this article, I will explore some of the intricacies of ‘investing in the tail’ and explore considerations for investing in secondary transactions in litigation finance investments. Slingshot Insights  For those investors interested in the litigation finance secondary market, I think it is important to approach the investment with caution and a high level of expert diligence to offset the implied volatility that the ‘tail’ of the portfolio offers.  It is also important to understand the motivations of the seller – a manager looking to create a track record will have different motivations than an investor who needs liquidity.  The seller’s motivations may also offer insight into the extent price can be negotiated. It is important not to lose sight of the typical loss rate of the industry and the fact that the tail should exhibit enhanced volatility (more losses) as compared to a whole portfolio, and so an investor should model their returns, and hence their entry price, accordingly. Should you choose to make a secondary investment, consider a variety of options to de-risk the investment by sharing risks and rewards with others (i.e. insurance providers or the vendor of the asset). Above all else, make sure your secondaries are diversified or part of a larger diversified pool of assets. As always, I welcome your comments and counter-points to those raised in this article. Edward Truant is the founder of Slingshot Capital Inc. and an investor in the consumer and commercial litigation finance industry.  Slingshot Capital inc. is involved in the origination and design of unique opportunities in legal finance markets, globally, investing with and alongside institutional investors

Does Legal Funding Generate Frivolous Lawsuits? Experts Say No

One of the most common assertions from Litigation Finance naysayers is that access to funding to pursue cases will result in frivolous lawsuits that lack merit. Claims that such filings will clog court dockets, especially at a time when delays relating to COVID are abound, continue to be rampant. But are they accurate? The second International Congress on Litigation Funding suggests that no, legal funding does not generate meritless lawsuits. Stonward explains that several arbitration experts gathered to discuss that very issue. Panelists included:
  • Antonio Bravo: Partner, Eversheds Sutherland
  • Daniel Rodriguez: Partner, CMS Rodriguez-Azuero
  • Luis Dates: Partner, Baker McKenzie
  • Heitor Castro: Portfolio Manager, LexFinance
  • Guido Demarco: Director, Stonward
Topics at hand included the assertion that litigation funding necessitates increased regulation around the globe. This is needed, some say, to prevent a flood of nuisance lawsuits that are essentially cash grabs for funders. But does that argument hold water?  First, let’s note that funding opponents assert that litigation funding “could” lead to a rise in frivolous claims. They do not assert that it has yet led there, despite Litigation Finance being a growth industry for more than a decade. Surely, if the number of meritless cases were going to increase—it would have done so by now in at least a few jurisdictions. Yet, that has not happened in any demonstrable way. Transparency and disclosure are still concerns from some anti-funding groups. This begs the question, is funding relevant to all cases? Or is disclosure a ploy by defense lawyers to obfuscate the facts of a case in favor of prejudicing a court? Panelists believe that disclosure should only follow actual relevance and avoid conflicts of interest. As such, no sweeping disclosure requirement should be legislated. Influence is another area of concern. But as LF agreements don’t allow funders to control settlement or strategy decisions, the point is essentially moot.

Legal Funding Looks Toward Interim Finance for Bankrupt Firms

Resolution professionals are increasingly turning to third-party legal funders in order to provide operating capital until liquidation is complete, or a new owner reorganizes the company. Economic Times explains that a corporate insolvency resolution process is a tenuous situation requiring a balancing act between making payments and keeping the business going. When lenders refuse to provide the needed funds, third-party funders can provide interim funds to cover costs. This type of financing, called debt-in-possession, has become increasingly popular in Australia, Canada, the US, and the UK. LegalPay CEO Kindan Sahi says that the India-based funder is targeting mid-market clients to fund these ongoing concerns until firms can support themselves.

Galactic Pulls Out of Hog’s Breath, Priceline Class Actions 

Levitt Robinson, class action lawyers leading the cases against Priceline and Hog’s Breath, estimate that it will take over $8 million to continue the Priceline case. The case is now in jeopardy, as funder Galactic Litigation Partners has pulled its financing. Executive Franchise Business details that class actions claimants in the Priceline case are likely to discontinue their pursuit of the case now that funding has dried up. The Hog’s Breath case is unfunded, and an order to provide $1.23 million in security for costs is outstanding. With one case being withdrawn and one on hold, it’s unclear if Levitt Robinson will be able to court the funding necessary to continue either claim.  

Litigation Funder Focuses on High Volume of Small Claims 

The United Kingdom is home to The Catch Litigation Fund (KLIF), a litigation investment portfolio that saw returns of about 16% during 2021. Traditionally, many ligation portfolios focus on a small number of high value claims, with long timelines for successful execution. What makes KLIF different is that managers invest in a high volume of lower value claims, with a shorter duration to maturity.  G., Opalesque Geneva recently issued a report on KLIF’s performance. Launched in 2020 with $56M, the fund focuses on financial services sector claims for investment. With an average loan of $6.7M, KLIF sports an average time for return on investment of just three to 24 months.  Organization is key to KLIF’s approach, and by partnering with attorney’s directly they are able to source claims with shorter overall durations. With this structure, the fund is able to loan directly to the firms representing cases. KLIF is run by Katch Investment Group, with offices across the UK, Europe and South America. Founded in 2018, the alternative investment fund manages over $800M in assets.

Omni Bridgeway Funds NovelStem Arbitration

The stem cell biotechnology firm NovelStem International Corporation has launched arbitration proceedings against NetCo Partners to maximize value from legacy entertainment publishing assets. Omni Bridgeway has been announced as the litigation funder backing NovelStem’s ambitions. NewsFileCorp.com’s press release on the developing matter outlines that NovelStem’s Chairman plans to extract value from their 50% stake in Netco Partners. Netco’s publishing arm, Net Force, has generated over $24M in total revenue since inception, and NovelStem anticipates substantial returns may be captured across digital, media and entertainment pillars.   NovelStem’s Chairman further details that litigation investment by Omni Bridgeway is enabling flexibility for broader investment in NewStem Ltd. Over the coming months, NovelStem plans to brief investors on the success of the NetCo Partners litigation and growth of NewStem Ltd.’s new investment dollars. 

Lion Air Flight 610 Victim’s Fund Embezzlement Probed by California State Bar 

With $2M missing from the Lion Air plane crash victims fund, California’s State Bar fears that disgraced attorney Tom Girardi may have embezzled the funds. Mr. Giradi was disbarred this past August, however, it appears that California investigators may have fallen prey to free gifts, plane rides and expensive wine from Girardi … allegedly tainting justice in the process.    DailyMail.co.uk reports that the State Bar of California is launching a new investigation into their handling of Tom Girardi’s potential malfeasances. The question is if Girardi has been able to buy his way out of discipline by California officials. A federal judge froze Girardi’s assets in 2020, after growing concern that he routinely misappropriated settlement funds to bankroll his Beverly Hills lifestyle.  Recently, Girardi was diagnosed with dementia and late stage Alzheimer's. Girardi has previously been sued by a slew of Law Firm Funders, each of whom made financial misappropriation claims against him.